Fundamental Neurochemistry Review: Microglial immunometabolism in traumatic brain injury
Traumatic brain injury (TBI) is a devastating neurological disorder caused by a physical impact to the brain that promotes diffuse damage and chronic neurodegeneration. Key mechanisms believed to support secondary brain injury include mitochondrial dysfunction and chronic neuroinflammation. Microgli...
Saved in:
Published in | Journal of neurochemistry Vol. 167; no. 2; pp. 129 - 153 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.10.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-3042 1471-4159 1471-4159 |
DOI | 10.1111/jnc.15959 |
Cover
Summary: | Traumatic brain injury (TBI) is a devastating neurological disorder caused by a physical impact to the brain that promotes diffuse damage and chronic neurodegeneration. Key mechanisms believed to support secondary brain injury include mitochondrial dysfunction and chronic neuroinflammation. Microglia and brain‐infiltrating macrophages are responsible for neuroinflammatory cytokine and reactive oxygen species (ROS) production after TBI. Their production is associated with loss of homeostatic microglial functions such as immunosurveillance, phagocytosis, and immune resolution. Beyond providing energy support, mitochondrial metabolic pathways reprogram the pro‐ and anti‐inflammatory machinery in immune cells, providing a critical immunometabolic axis capable of regulating immunologic response to noxious stimuli. In the brain, the capacity to adapt to different environmental stimuli derives, in part, from microglia's ability to recognize and respond to changes in extracellular and intracellular metabolite levels. This capacity is met by an equally plastic metabolism, capable of altering immune function. Microglial pro‐inflammatory activation is associated with decreased mitochondrial respiration, whereas anti‐inflammatory microglial polarization is supported by increased oxidative metabolism. These metabolic adaptations contribute to neuroimmune responses, placing mitochondria as a central regulator of post‐traumatic neuroinflammation. Although it is established that profound neurometabolic changes occur following TBI, key questions related to metabolic shifts in microglia remain unresolved. These include (a) the nature of microglial mitochondrial dysfunction after TBI, (b) the hierarchical positions of different metabolic pathways such as glycolysis, pentose phosphate pathway, glutaminolysis, and lipid oxidation during secondary injury and recovery, and (c) how immunometabolism alters microglial phenotypes, culminating in chronic non‐resolving neuroinflammation. In this basic neurochemistry review article, we describe the contributions of immunometabolism to TBI, detail primary evidence of mitochondrial dysfunction and metabolic impairments in microglia and macrophages, discuss how major metabolic pathways contribute to post‐traumatic neuroinflammation, and set out future directions toward advancing immunometabolic phenotyping in TBI.
image |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 No Brian M. Polster, PhD Department of Anesthesiology and Center for Shock, Trauma and Anesthesiology Research, University of Maryland School of Medicine, 685 W. Baltimore St., MSTF 5-34, Baltimore, MD 21201, USA, bpolster@som.umaryland.edu "All experiments were conducted in compliance with the ARRIVE guidelines." unless it is a Review or Editorial NRS: Conceptualization, Writing - Original Draft, Writing - Review & Editing, Funding acquisition. LVP: Writing - Review & Editing, Funding acquisition. BMP: Writing - Review & Editing, Funding acquisition. DJL: Conceptualization, Writing - Original Draft, Writing - Review & Editing, Funding acquisition. if it is a Review or Editorial, skip complete sentence Author contribution statement Author contributions-- NA if No, include a statement in the "Conflict of interest disclosure" section: "ARRIVE guidelines were not followed for the following reason ARRIVE guidelines have been followed (edit phrasing to form a complete sentence as necessary). Luis Valmor Portela, PhD, Laboratory of Neurotrauma and Biomarkers, Departamento de Bioquímica, ICBS, Universidade Federal do Rio Grande do Sul, UFRGS, Rua Ramiro Barcelos 2600, anexo, Bairro Santana, Porto Alegre, RS, Brasil, roskaportela@gmail.com if Yes, insert in the "Conflict of interest disclosure" section |
ISSN: | 0022-3042 1471-4159 1471-4159 |
DOI: | 10.1111/jnc.15959 |